key: cord-0688027-jght88ba authors: Bennasrallah, Cyrine; Zemni, Imen; Dhouib, Wafa; Sriha, Haythem; Mezhoud, Nourhene; Bouslama, Samar; Taboubi, Wael; Beji, Meriem Oumaima; Kacem, Meriem; Abroug, Hela; Fredj, Manel Ben; Loussaief, Chawki; Belguith, Asma Sriha title: Factors Associated with a prolonged negative conversion of viral RNA in patients with Coronavirus Disease 2019 (COVID-19) date: 2021-02-27 journal: Int J Infect Dis DOI: 10.1016/j.ijid.2021.02.089 sha: 367755f7bec44f351bfa98d39adfe3c1abda72ac doc_id: 688027 cord_uid: jght88ba Objectives Our study aimed to identify the factors influencing the delay in SARS-CoV-2 RNA negative conversion. Methods A cohort study including COVID-19 patients admitted to the Tunisian national containment center was conducted. The follow-up consisted of a weekly RT-PCR test. Multivariate Cox regression analysis was performed to determine independent predictors associated to negative RNA conversion. Results Among 264 patients included, the median duration of viral clearance was 20 days (IQR (Interquartile Range), 17–32). The shortest and longest durations were nine and 58 days, respectively. Associated factors to negative conversion of viral RNA, were symptoms such as fatigue, fever and shortness of breath (HR (Hazard Ratio): 0.600; 95% CI: 0.401-0.897) and face masks use when exposed to COVID-19 cases (HR: 2.006; 95%CI:1.247-3.228). The median time to RNA viral conversion was 18 days (IQR, 16-21) when using masks vs 23 days (IQR, 17-36) without wearing masks, and 24 days (IQR, 18-36) for symptomatic patients vs 20 days (IQR, 16-30) for asymptomatic ones. Conclusion Our results revealed that during SARS-CoV-2 infection, having symptoms delayed viral clearance, while wearing masks accelerated this conversion. These factors should be harp on consideration for the strategy of isolating infected patients. Our results revealed that during SARS-CoV-2 infection, having symptoms delayed viral clearance, while wearing masks accelerated this conversion. These factors should be harp on consideration for the strategy of isolating infected patients. Coronavirus disease 2019 , SARS-CoV-2, viral shedding, negative conversion, Tunisia Introduction: Since December 2019, cases of pneumonia of unknown etiology were reported in Wuhan, Hubei province, China ). On February, the world health organization (WHO) named this emerging disease as coronavirus disease 2019 (COVID-19) and the responsible agent was identified as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Lai et al. 2020 ). The current COVID-19 pandemic, is spreading worldwide at an accelerated rate. According to World Health Organization (WHO), as of 14 February 2021, approximately 108,153,741confirmed cases have been estimated globally with surpassing 2 381 295 deaths spanning over 216 countries Dashboard' n.d.) In Tunisia, since March 22, our country has experienced a turning point and general health containment has begun. Tunisia's strategy was based on testing, tracing and isolation as the WHO guidelines. Tunisia's government and health ministry have launched a series of measures to screen, quarantine, diagnose, treat and monitor suspected patients and their close contacts. The lifting of the compulsory confinement of SARS-CoV-2 carrying subjects in a dedicated center was announced on July 14. Tunisia is experiencing a second wave of the pandemic infection rate and COVID-19 is spreading exponentially. Until the 14 th of February, there have been 222 504 confirmed cases of COVID-19 with 7 508 deaths ('Tunisia: Dashboard' n.d.). Since the identification of the first cases of COVID-19, numerous studies were released and focused on the epidemiological, clinical, radiological characteristics and treatment strategies of infected patients in Tunisia. However, there is limited data regarding the potential factors associated with the delay in RNA negative conversion of patients with COVID-19 (Hu et al. 2020 ). The patient's infectivity is determined by the presence of the virus in body fluids, secretions, and excreta (Ling et al. 2020 ). All patients with positive viral RNA detection need to be isolated, and only after the relief of symptoms and two successive negative viral nucleic acid results for respiratory specimens, the isolated cases can be discharged (Qi et al. 2020) . The persistence and clearance of viral RNA predictors in different specimens of COVID-19 patients remains unclear. Knowledge has been accumulating in this topic about hospitalized and critically ill patients, while information about patients with mild severity is scarce (Ling et al. 2020; Qi et al. 2020; Wang et al. 2020) . Although, most COVID-19 patients have mild clinical symptoms (Qi et al. 2020) . Data on viral RNA shedding among patients with mild COVID-19, are of paramount importance to prevent transmission of this disease. Indeed, identifying people likely to be slow shedders is crucial to prolong their isolation, once infected, and avoid the virus spread, especially with the impossibility of confirming negative conversion by two reverse transcription-polymerase chain reaction (RT-PCR) tests due to the international shortage and increasing cases. Thus, understanding factors associated with prolonged viral clearance among asymptomatic/mild cases is important to tailor prevention strategies. Our study aimed to identify the potential predictors of RNA negative conversion delay among these COVID-19 patients. A cohort study was conducted including patients with confirmed COVID-19 confined in the national COVID-19 center from March to July 2020. National COVID-19 center (Hotel for COVID-19 patients) was located in Monastir governorate. This community facility was designated for isolation of patients with or without symptoms of COVID-19 in Tunisia (from the 24 Tunisian governorates). The Tunisian government allocated asymptomatic or mild COVID-19 cases to dedicated isolation facilities and the remaining individuals with moderate-to-severe COVID-19 to hospitals. The recruitment period spread out from March to 29 th of July, 2020. Exposure to isolation and follow-up for each case ranged from admission to the recovery announcement. A prospective daily data collection was made. Patients over 18 years of age with positive detection of SARS-CoV-2 RNA from nasopharyngeal / throat swabs by real-time reverse transcription-polymerase chain reaction (RT-PCR) were included. All cases progressing to a moderate or severe form requiring hospitalization were excluded for analysis ( Figure 1 were discharged from the containment center. Outcome: Conversion of viral RNA was defined as the duration from the first day of RT-PCR result till the second successively negative RNA SARS-CoV-2 testing, as proposed by previous studies dealing with a similar topic (Hu et al. 2020; Gao and Li 2020) . A SARS-CoV-2 infection was confirmed by testing respiratory specimens based on RT-PCR assays from different agreed institutions including the Monastir university laboratory. Exposure: Patients are required to stay in their hotel rooms during the isolation period. Their meals were served in their rooms. Telephone medical assistance was provided on a daily basis by Monastir preventive medicine department team. A toll-free number is given to each patient for any emergency to be resolved by the containment center staff. Predictors and diagnostic criteria: Initially, demographic and clinical characteristics were collected. A daily phone call was made to collect clinical evolution and provide information on compliance with isolation measures. Patients were also asked if they wore a mask when exposed to index cases and when they had contracted the virus, and whether they lived in a single room or not. The announcement of recovery is made after the 2 nd negative RT PCR, addressed by laboratory in 24 to 48 hours. After recovery, the patients were asked about their degree of implication in respecting hygiene and isolation measures. were discharged based on respiratory samples consecutively negative for RNA testing with an interval of at least one day. Continuous variables were presented as means and standard deviation and as medians and interquartile (IQR). Categorical variables were described as frequency and percentage. The Mann-Whitney U test was introduced to compare the differences between two groups for quantitative variables. In our study, negative conversion of viral RNA during the communicable period, as time-toevent data, was the outcome measure and was illustrated with Kaplan-Meier curves. In order to detect the independent factors influencing the duration of RNA negative conversion, univariate and multivariate analysis were performed. The log-rank test was first conducted with demographic, epidemiological, clinical, and virological variables. Multivariate Cox regression model was then performed with the significant factors selected by univariate analysis (p-value less than 0.2) to determine the independent predictors for RNA negative conversion. The association between independent factors and negative conversion was quantified by hazard ratio (HR). As negative conversion of viral RNA is a favorable event, HR value >1 would accelerate virological clearance, whereas HR <1 means the independent predictor would delay negative conversion. A p-value less than 0.05 was considered statistically significant. Analyses were performed using SPSS software (version 21.0). Symptoms such as anosmia, dry cough, and fatigue were reported by 34.4% (75) of cases. Detailed demographic and clinical characteristics of our included patients were represented in Table 1 . The median duration of viral conversion in the current study was 20 days (IQR, 17-32). The shortest and longest durations were nine days and 58 days, respectively. The patient with the J o u r n a l P r e -p r o o f shortest RNA-viral clearance duration was a 43-year-old male with no comorbidities. As for the longest 58 days duration, the concerned patient was a 62-year-old male with hypertension. No symptoms were reported during RT-PCR positivity for both cases. Kaplan-Meier survival curve representing the overall negative conversion of viral RNA in COVID-19 patients was illustrated in figure 2. By age categories, the median time to viral clearance was described in Table 2 . We evaluated the effect of each factor on negative conversion of COVID-19 patients by Log rank test (figure 3). We found that SARS-CoV-2 RNA clearance was significantly delayed in symptomatic patients (log-rank test, p=0.041; Figure 2C ). The median duration was 24 days J o u r n a l P r e -p r o o f Moreover, according to our findings, viral RNA negative conversion was significantly faster in patients with dyslipidemia (log-rank test, p=0.016; Figure 2D ), and cases who were wearing face masks when contracting the virus (log-rank test, p=0.003; Figure 2F ). The median time to RNA viral conversion was 18 days (IQR, 16-21) for patients using face masks vs 23 days (IQR, 17-36) for patients who did not wear it. There was no significant difference in duration of SARS-CoV-2 RNA negative conversion according to sex (Figure 2A) , over 60 years age ( Figure 2B ), current smoking, comorbidities and isolation in a single room ( Figure 2E ). Key results: Until now, there has been little studies on the predictors of negative conversion of SARS-CoV-2 RNA duration. Viral shedding was related to infectivity and transmissibility in influenzae virus infections, which understanding is crucial for the implementation of prevention strategies (Ryoo et al. 2013) . Therefore, it is important to determine the duration of viral shedding and related factors in patients with COVID-19 (Qi et al. 2020 ). Our study showed associations between face-masking, having symptoms and RNA conversion duration. The median time to RNA viral conversion was 18 days (IQR, 16-21) for cases who wore mask when contacting index cases vs 23 days (IQR, 17-36) who did not wear a mask and 24 days (IQR, 18-36) for symptomatic patients vs 20 days (IQR, 16-30) for asymptomatic ones. Interpretation : The median time to viral conversion observed in our cohort was 20 (IQR: 17-32) days from the first positive RT-PCR test, similar to Zhou et al study (Zhou et al. 2020) . Other studies demonstrated a shorter median duration of viral shedding of 9.5 (IQR:6.0-11.0) and 14 (IQR:10-18) days (Hu et al. 2020; Ling et al. 2020) . Another study in Italy reported a longer median duration of viral shedding of 31 (IQR:24-41) days (Mancuso et al. 2020 ). The discrepancies might be attributed to the heterogeneity of patients and disease severity in these studies. Differences may also come from the different starting points of the RNA viral clearance in previous reports. In our study, the definition was in line with other high-quality studies as mentioned in methods section (Hu et al. 2020; Gao and Li 2020) . According to our study, sex difference was not related to the duration of viral shedding. However, a previous study showed that male sex was a predictor of SARS-CoV-2 RNA prolonged clearance . The mechanism of sex-related difference in SARS-CoV-2 infection is unclear. It might be related to sex hormones which appear to influence the immune system. Females are reported to produce more cellular and humoral immune reactions, and so are more resistant to certain infections (Bouman, Heineman, and Faas 2005) . Smoking rates were not a predictor of a prolonged viral shedding in line with what was reported in a previous study . A Meta-analysis based on 19 peer reviewed papers, demonstrated a significant association between smoking and progression of COVID-19 (Patanavanich and Glantz 2020) . Indeed, the adverse effects of smoking on pulmonary immune function is a risk factor for serious outcomes among infected people (Bauer, Morissette, and Stämpfli 2013) . Health care providers should take active measures to slow smoker's trend, and public health campaigns should underline the importance of smoking cessation during the pandemic. Furthermore, the current study does not support diabetes and hypertension as a predisposing factor a late SARS-CoV-2 viral clearance similar to previous studies (Hu et al. 2020; Li et al. n.d.) . Our study showed no increase in time to viral clearance with increasing age. Besides, older age (over 60 years) was not found to be an independent predictive factor of prolonged viral RNA shedding. Similarly, a recent systematic review reported no significant age related differences in the duration of both respiratory tract swab positivity and fecal sample positivity (Morone et al. 2020) . Even though, it was demonstrated that growth age was correlated to a later RT-PCR conversion (Hu et al. 2020; Mori et al. 2020) . COVID-19 is more likely to infect older patients due to the weaker immune system (K. . Indeed, T-cell numbers and functions are highly affected with aging, leading to a less controlled viral replication and host inflammatory responses (Goronzy, Lee, and Weyand 2007) . Besides, agerelated comorbidities may result in prolonged viral shedding among elderly (K. ). However, no significant difference was noted concerning comorbidities in the current study; the effect of age on the RNA viral clearance in patients with COVID-19 still needs further investigation. Interestingly, not wearing masks and having symptoms were associated with a prolonged viral clearance RNA. Virological and epidemiological data, have led to the hypothesis that facial masking may reduce the severity among infected people (Gandhi and Rutherford 2020) . In an outbreak on a closed Argentinian cruise ship, the rate of asymptomatic infection among passengers wearing surgical and N95 masks was 81% compared with 20% without masking (Gandhi, Beyrer, and Goosby 2020) . Masking could reduce administered virus doses leading to less severe manifestations of COVID-19. Long lasting negative conversion RNA might also be proportionate to the viral SARS-CoV-2 inoculum received explaining the association between facial masking and viral shedding in our findings. This perspective puts another advantage to population-wide masking for pandemic control regarding viral inoculum, attenuating severe disease and acceleration SARS-CoV-2 recovery. Enforced population masking is the key strategy now as we await the results of vaccine trials. Therefore, strategic guidance should be established, and enough mask supply should be guaranteed. Developing symptoms was a predictor of prolonged negative RNA conversion. Mild cases were found to have an early clearance in contrast with severe case, in which mean viral load was 60 times higher than that of mild cases, suggesting that higher viral loads might be associated with a longer viral shedding period (Y. ). However and unexpectedly, previous studies reported that viral load of asymptomatic SARS-CoV-2 patients was as high as that of symptomatic patients (Lee et al. 2020; Zou et al. 2020) . Our data indicate that patients with symptoms tend to have a prolonged viral clearance which might be a useful marker for assessing disease prognosis. Our study has some limitations. First, we only analyzed RNA in nasal swats and not in patients' excretions such as urine and feces. However, previous studies showed that viral loads in patients' excretions might be higher than respiratory specimens (Li et al. n.d.) . Second there are only qualitative results of RNA detection in this study, but the persistent positivity of SARS-CoV-2 RNA does not necessarily show persistent shedding of live virus. To date, it is unknown how shedding of viral RNA correlates with shedding of infectious virus needing further studies. Our results highlighted the point that asymptomatic and symptomatic COVID-19 cases will test positive for SARS-COV-2 when released according to the latest WHO recommendation There was no external funding for this article J o u r n a l P r e -p r o o f The Influence of Cigarette Smoking on Viral Infections: Translating Bench Science to Impact COPD Pathogenesis and Acute Exacerbations of COPD Clinically Criteria for Releasing COVID-19 Patients from Isolation'. n.d. Accessed 4 Masks Do More Than Protect Others During COVID-19: Reducing the Inoculum of SARS-CoV-2 to Protect the Wearer' Facial Masking for Covid-19 -Potential for "Variolation" as We Await a Vaccine' Advances on presymptomatic or asymptomatic carrier transmission of COVID-19 Aging and T-Cell Diversity' Factors Associated with Negative Conversion of Viral RNA in Patients Hospitalized with COVID-19 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease-2019 (COVID-19): The Epidemic and the Challenges' Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea Duration of SARS-CoV-2 RNA Shedding and Factors Associated with Prolonged Viral Shedding in Patients with COVID-19' Persistence and Clearance of Viral RNA in 2019 Novel Coronavirus Disease Rehabilitation Patients Clinical Features of COVID-19 in Elderly Patients: A Comparison with Young and Middle-Aged Patients Viral Dynamics in Mild and Severe Cases of COVID-19 Temporal Profile and Determinants of Viral Shedding and of Viral Clearance Confirmation on Nasopharyngeal Swabs from SARS-CoV-2-Positive Subjects: A Population-Based Prospective Cohort Study in Reggio Emilia, Italy Comparison of COVID-19 Disease between Young and Elderly Patients: Hidden Viral Shedding of COVID-19 Incidence and Persistence of Viral Shedding in COVID-19 Post-Acute Patients With Negativized Pharyngeal Swab: A Systematic Review' Smoking Is Associated With COVID-19 Progression: A Meta-Analysis'. Nicotine & Tobacco Research Factors Associated with the Duration of Viral Shedding in Adults with COVID-19 Outside of Wuhan, China: A Retrospective Cohort Study Factors Promoting the Prolonged Shedding of the Pandemic (H1N1) 2009 Influenza Virus in Patients Treated with Oseltamivir for 5 Days Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Single-Center 28-Day Study Differences of Severe Acute Respiratory Syndrome Coronavirus 2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens Among Adult Inpatients With Coronavirus Disease Factors Associated with Prolonged Viral RNA Shedding in Patients with COVID-19'. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients' Committee ethics of the faculty of medicine of Monastir approved the protocol of this study.To maintain the principle of confidentiality, the data used were anonymized. Not applicable. We do not have any conflicts of interest associated with this publication. There is no significant financial support for this work that could have influenced its outcome.